Efficacy of the novel CDK7 inhibitor QS1189 in mantle cell lymphoma

Mantle cell lymphoma (MCL) is typically an aggressive and rare form of non-Hodgkin lymphoma (NHL) with a poor prognosis despite recent advances in immunochemotherapy and targeted therapeutics against NHL. New therapeutic agents are needed for MCL. In this study, we generated a potent inhibitor of cy...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Yun Jung, Kim, Dong Ha, Yoon, Dok Hyun, Suh, Cheolwon, Choi, Chang-Min, Lee, Jae Cheol, Hong, Jung Yong, Rho, Jin Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510728/
https://www.ncbi.nlm.nih.gov/pubmed/31076643
http://dx.doi.org/10.1038/s41598-019-43760-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510728/
https://www.ncbi.nlm.nih.gov/pubmed/31076643
http://dx.doi.org/10.1038/s41598-019-43760-z

Ejemplares similares